The Goldman Sachs Group has recently lowered the price target for InnovAge (NASDAQ:INNV) from $9.00 to $8.00, according to a research note issued to investors. The stock opened at $7.59 on Wednesday.
InnovAge is a company that manages and provides a range of medical and ancillary services for seniors who need care and support to live independently in their homes and communities. The company operates through the Program of All-Inclusive Care for the Elderly (PACE) approach, offering a variety of services such as in-home care, in-center services, transportation, and care management.
Despite the decrease in the price target, InnovAge has shown positive trading activity, with its shares trading up by 11.8% recently. The company has a twelve-month low of $4.46 and a twelve-month high of $8.15. It has a market capitalization of $1.03 billion, a price-to-earnings ratio of -24.48, and a beta of 0.16.
InnovAge’s financial health is reflected in its quick ratio of 1.57 and current ratio of 1.45, indicating its ability to meet short-term financial obligations. Additionally, the company has a debt-to-equity ratio of 0.26, which suggests a conservative level of debt.
With its focus on providing comprehensive care services for seniors, InnovAge plays a crucial role in supporting the aging population’s needs. As the demand for senior care continues to grow, companies like InnovAge are well-positioned to address these evolving needs.
The Goldman Sachs Group has recently lowered the price target for InnovAge (NASDAQ:INNV) from $9.00 to $8.00, according to a research note issued to investors. The stock opened at $7.59 on Wednesday.
InnovAge is a company that manages and provides a range of medical and ancillary services for seniors who need care and support to live independently in their homes and communities. The company operates through the Program of All-Inclusive Care for the Elderly (PACE) approach, offering a variety of services such as in-home care, in-center services, transportation, and care management.
Despite the decrease in the price target, InnovAge has shown positive trading activity, with its shares trading up by 11.8% recently. The company has a twelve-month low of $4.46 and a twelve-month high of $8.15. It has a market capitalization of $1.03 billion, a price-to-earnings ratio of -24.48, and a beta of 0.16.
InnovAge’s financial health is reflected in its quick ratio of 1.57 and current ratio of 1.45, indicating its ability to meet short-term financial obligations. Additionally, the company has a debt-to-equity ratio of 0.26, which suggests a conservative level of debt.
With its focus on providing comprehensive care services for seniors, InnovAge plays a crucial role in supporting the aging population’s needs. As the demand for senior care continues to grow, companies like InnovAge are well-positioned to address these evolving needs.
Hi there, I am Amanda and I work as an editor at impactinvesting.ai; if you are interested in my services, please reach me at amanda.impactinvesting.ai
